As a bioentrepreneur in the highest stakes arena of any industry, if you are treating your innovation’s path to market with antiquated methods, you miss out on an advantage over your competition. Read More
Understand key drivers of the value conversation and how the definition of value goes beyond quality & cost of care to include other dimensions that should be factored into developing value frameworks Read More
Cybersecurity is a growing threat in the Life Sciences Industry. This whitepaper takes a deep dive into the risks that are challenging the Life Sciences sector, and how to best mitigate those risks. Read More
KCR recently hosted a seminar for the life science community in Boston to discuss the most important things to know about GDPR before executing clinical trials in Europe. Read More
Evidera had several representatives in attendance at NICE's Annual Conference to garner insight into their perspective on improving access to innovative treatments and what it means for our clients. Read More
In the 2019 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of current and evolving trends that are shaping the future of the industry. Read More
This guide walks US-based clinical supply professionals through the EU GMP Annex 13 labeling requirements. Read More
Through a combination of new legislation, regulations, and enforcement policies, a new regulatory framework is coming for OTC drugs. Read More
What does the word “feasibility” mean to you? It may seem like a simple question, but I have found that “feasibility” has many interpretations within the clinical research industry. When we work with Read More
The requirement that new drugs show effectiveness is based on a 1962 amendment to the Federal Food, Drug, and Cosmetic Act. This law requires substantial evidence of effectiveness and specifies that t Read More
